Previously reported studies in colon cancer cells postulate that rosemary compounds exert antiproliferative effects by inhibiting proliferative and survival signaling pathways such as PI3K/Akt, as well as modulating Nrf2 transcription factor pathway18,47. This evidence concerns the gene AKT1 and malignant colon neoplasm.